Temperature-controlled container provider SkyCell and Air France KLM Martinair (AF-KLM Cargo) will expand their existing collaboration, to work more closely on pharma logistics.
Richard Ettl, the chief executive of Switzerland-based manufacturer SkyCell, said: “With a shared vision of innovation in the supply chain of temperature-sensitive products, our collaboration will ensure that consumers are guaranteed a safe and sustainable service. We will also further improve our services through SkyCell’s data-driven approach.”
Enrica Calonghi, global head of pharma logistics at AF-KLM Cargo, said: “SkyCell is driven by technological innovation in pharma transport technology and that is why we want to work very close together.”
In a recent transport of temperature-sensitive vaccines by AF-KLM Cargo, two SkyCell containers were used, one SkyCell 1500c and one SkyCell 2500c, set at a temperature of +5° Celsius.
The British pharma company shipment was transported from Rome-Fiumicino to Washington Dulles International Airport “without any temperature excursions and in due time in order to deliver medicines through the US,” said the companies in a statement.
They added: “Twelve of the 20 largest pharmaceutical manufacturers globally have independently validated the service offering of SkyCell and implemented its usage into their supply chain. SkyCell is already the fourth largest container company in air freight and represents the largest fleet of Internet of Things plugged-in containers in the world.”
Richard Ettl, SkyCell CEO
